EUDA Health Holdings Limited (EUDA)
Automate Your Wheel Strategy on EUDA
With Tiblio's Option Bot, you can configure your own wheel strategy including EUDA - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol EUDA
- Rev/Share 0.1389
- Book/Share -0.1003
- PB -13.623
- Debt/Equity -0.6158
- CurrentRatio 0.2289
- ROIC 1.54
- MktCap 50128433.0
- FreeCF/Share -0.0568
- PFCF -23.7532
- PE 189.5019
- Debt/Assets 1.0763
- DivYield 0
- ROE -0.0852
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
EUDA Integrates QB Utility Token to Create a Digital Health and Rewards Platform Across Its Healthcare Ecosystem
Published: December 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
SINGAPORE, Dec. 22, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) “EUDA” or “the Company”, a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced a strategic technology integration that would introduce the QB utility token into its digital health and rewards platform. The QB utility token is being created, developed, and issued solely by QB Limited, a company incorporated in Hong Kong with limited liability under the Hong Kong Companies Ordinance. QB Limited is also the exclusive distributor of the EUDA Helixe supplement in Hong Kong and Macau.
Read More
EUDA Health Holdings Limited Announces Execution of Securities Purchase Agreement
Published: December 05, 2025 by: GlobeNewsWire
Sentiment: Neutral
SINGAPORE, Dec. 05, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or “the Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that it entered into a securities purchase agreement on November 26, 2025 with Streeterville Capital, LLC, a Utah limited liability company, for the sale of a convertible warrant (the “Warrant”) for an aggregate purchase price of US$100,000. The Warrant is exercisable for up to 2,000,000 newly issued EUDA ordinary shares (the “Warrant Shares”) at an exercise price of US$6.00 per share and is being offered pursuant to the …
Read More
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
Published: September 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
SINGAPORE, Sept. 10, 2025 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned subsidiary, EUDA Health Pte. Ltd. (“EUDA Health”), has signed a Letter of Intent (the “LOI”) to potentially acquire GO POSB Organoids Pte Ltd (“GO POSB”), a biotechnology company formed in Singapore.
Read More
About EUDA Health Holdings Limited (EUDA)
- IPO Date 2021-12-14
- Website https://euda.com
- Industry Medical - Healthcare Information Services
- CEO Alfred Lim
- Employees 117